Search Results - Deborah Kuk

Refine Results
  1. 1
    Analysis of Outcomes in Extraskeletal Osteosarcoma

    Analysis of Outcomes in Extraskeletal Osteosarcoma by Lisa Choi, John H. Healey, Deborah Kuk, Murray F. Brennan

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Bone Marrow Minimal Residual Disease Was an Early Response Marker and a Consistent Independent Predictor of Survival After Anti-GD2 Immunotherapy

    Bone Marrow Minimal Residual Disease Was an Early Response Marker and a Consistent Independent Predictor of Survival After Anti-GD2 Immunotherapy by Nai‐Kong V. Cheung, Irina Ostrovnaya, Deborah Kuk, Irene Y. Cheung

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Secondary cancers after intensity‐modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause‐specific survival outcomes according to the initial treatment intervention

    Secondary cancers after intensity‐modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause‐specific survival outcom... by Michael J. Zeléfsky, Xin Pei, Tatiana Teslova, Deborah Kuk, Juan Martin Magsanoc, Marisa Kollmeier, Brett Cox, Zhigang Zhang

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Optimal Percent Myxoid Component to Predict Outcome in High-Grade Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma

    Optimal Percent Myxoid Component to Predict Outcome in High-Grade Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma by Ann Y. Lee, Narasimhan P. Agaram, Li‐Xuan Qin, Deborah Kuk, Christina Curtin, Murray F. Brennan, Samuel Singer

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-G<sub>D2</sub>immunotherapy and isotretinoin: a prospective Phase II study

    Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-G<sub>D2</sub>immunotherapy and isotretinoin: a prospective Phase II s... by Brian H. Kushner, Irina Ostrovnaya, Irene Y. Cheung, Deborah Kuk, Kim Kramer, Shakeel Modak, Karima Yataghene, Nai‐Kong V. Cheung

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Comparison of Local Recurrence With Conventional and Intensity-Modulated Radiation Therapy for Primary Soft-Tissue Sarcomas of the Extremity

    Comparison of Local Recurrence With Conventional and Intensity-Modulated Radiation Therapy for Primary Soft-Tissue Sarcomas of the Extremity by Michael R. Folkert, Samuel Singer, Murray F. Brennan, Deborah Kuk, Li-Xuan Qin, Wendy Kobayashi, Aimeé M. Crago, Kaled M. Alektiar

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Real-World Evidence In Support Of Precision Medicine: Clinico-Genomic Cancer Data As A Case Study

    Real-World Evidence In Support Of Precision Medicine: Clinico-Genomic Cancer Data As A Case Study by Vineeta Agarwala, Sean Khozin, Gaurav Singal, Claire O’Connell, Deborah Kuk, Gerald Li, Anala Gossai, Vincent A. Miller, Amy P. Abernethy

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Long-term outcomes following microwave ablation for liver malignancies

    Long-term outcomes following microwave ablation for liver malignancies by Universe Leung, Deborah Kuk, Michael I. D’Angelica, T. Peter Kingham, Peter J. Allen, Ronald P. DeMatteo, William R. Jarnagin, Yuman Fong

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Key role for myeloid cells: Phase II results of anti‐G<sub>D2</sub> antibody 3F8 plus granulocyte‐macrophage colony‐stimulating factor for chemoresistant osteomedullary neuroblastoma

    Key role for myeloid cells: Phase II results of anti‐G<sub>D2</sub> antibody 3F8 plus granulocyte‐macrophage colony‐stimulating factor for chemoresistant osteomedullary neuroblasto... by Nai‐Kong V. Cheung, Irene Y. Cheung, Kim Kramer, Shakeel Modak, Deborah Kuk, Neeta Pandit‐Taskar, Elizabeth Chamberlain, Irina Ostrovnaya, Brian H. Kushner

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma

    Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma by Marcus Tan, Murray F. Brennan, Deborah Kuk, Narasimhan P. Agaram, Cristina R. Antonescu, Li‐Xuan Qin, Nicole H. Moraco, Aimeé M. Crago, Samuel Singer

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Neoadjuvant and Adjuvant Chemotherapy in Resected Pulmonary Large Cell Neuroendocrine Carcinomas: A Single Institution Experience

    Neoadjuvant and Adjuvant Chemotherapy in Resected Pulmonary Large Cell Neuroendocrine Carcinomas: A Single Institution Experience by Inderpal S. Sarkaria, Akira Iyoda, Mee Soo Roh, Gabriel Sica, Deborah Kuk, Camelia S. Sima, M. Catherine Pietanza, Bernard J. Park, William D. Travis, Valerie W. Rusch

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin

    Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin by Brian H. Kushner, Irina Ostrovnaya, Irene Y. Cheung, Deborah Kuk, Shakeel Modak, Kim Kramer, Stephen S. Roberts, Ellen M. Basu, Karima Yataghene, Nai‐Kong V. Cheung

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma

    Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma by Jian Zheng, Deborah Kuk, Mithat Gönen, Vinod P. Balachandran, T. Peter Kingham, Peter J. Allen, Michael I. D’Angelica, William R. Jarnagin, Ronald P. DeMatteo

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Pretreatment Serum VEGF Is Associated with Clinical Response and Overall Survival in Advanced Melanoma Patients Treated with Ipilimumab

    Pretreatment Serum VEGF Is Associated with Clinical Response and Overall Survival in Advanced Melanoma Patients Treated with Ipilimumab by Jianda Yuan, Jun Zhou, Zhiwan Dong, Sapna Tandon, Deborah Kuk, Katherine S. Panageas, Phillip Wong, Xinqi Wu, Jarushka Naidoo, David B. Page, Jedd D. Wolchok, F. Stephen Hodi

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Comparison of Perioperative Radiation Therapy and Surgery Versus Surgery Alone in 204 Patients With Primary Retroperitoneal Sarcoma

    Comparison of Perioperative Radiation Therapy and Surgery Versus Surgery Alone in 204 Patients With Primary Retroperitoneal Sarcoma by Kaitlyn J. Kelly, Sam S. Yoon, Deborah Kuk, Li‐Xuan Qin, Katerina Dukleska, Kevin K. Chang, Yen‐Lin Chen, Thomas F. DeLaney, Murray F. Brennan, Samuel Singer

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Robotic Liver Resection: A Case‐Matched Comparison

    Robotic Liver Resection: A Case‐Matched Comparison by T. Peter Kingham, Universe Leung, Deborah Kuk, Mithat Gönen, Michael I. D’Angelica, Peter J. Allen, Ronald P. DeMatteo, Vincent P. Laudone, William R. Jarnagin, Yuman Fong

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Bone Metastases in Castration-Resistant Prostate Cancer: Associations between Morphologic CT Patterns, Glycolytic Activity, and Androgen Receptor Expression on PET and Overall Survival

    Bone Metastases in Castration-Resistant Prostate Cancer: Associations between Morphologic CT Patterns, Glycolytic Activity, and Androgen Receptor Expression on PET and Overall Surv... by Hebert Alberto Vargas, Cecilia Wassberg, Josef J. Fox, Andreas G. Wibmer, Debra A. Goldman, Deborah Kuk, Mithat Gönen, Steven M. Larson, Michael J. Morris, Howard I. Scher, Hedvig Hricak

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Targeted exome sequencing profiles genetic alterations in leiomyosarcoma

    Targeted exome sequencing profiles genetic alterations in leiomyosarcoma by Narasimhan P. Agaram, Lei Zhang, Francois V. LeLoarer, Tarik Silk, Yun‐Shao Sung, Sasinya N. Scott, Deborah Kuk, Li‐Xuan Qin, Michael F. Berger, Cristina R. Antonescu, Samuel Singer

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer

    Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer by Iain J. Nixon, Deborah Kuk, Volkert B. Wreesmann, Luc G.T. Morris, Frank L. Palmer, Ian Ganly, Snehal G. Patel, Bhuvanesh Singh, R. Michael Tuttle, Ashok R. Shaha, Mithat Gönen, Jatin P. Shah

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Computational Algorithm-Driven Evaluation of Monocytic Myeloid-Derived Suppressor Cell Frequency for Prediction of Clinical Outcomes

    Computational Algorithm-Driven Evaluation of Monocytic Myeloid-Derived Suppressor Cell Frequency for Prediction of Clinical Outcomes by Shigehisa Kitano, Michael A. Postow, Carly G.K. Ziegler, Deborah Kuk, Katherine S. Panageas, Czrina Cortez, Teresa Rasalan, Matthew Adamow, Jianda Yuan, Phillip Wong, Grégoire Altan‐Bonnet, Jedd D. Wolchok, Alexander M. Lesokhin

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: